[go: up one dir, main page]

AR096942A1 - Métodos para promocionar el desarrollo neuronal y/o la salud - Google Patents

Métodos para promocionar el desarrollo neuronal y/o la salud

Info

Publication number
AR096942A1
AR096942A1 ARP140102630A ARP140102630A AR096942A1 AR 096942 A1 AR096942 A1 AR 096942A1 AR P140102630 A ARP140102630 A AR P140102630A AR P140102630 A ARP140102630 A AR P140102630A AR 096942 A1 AR096942 A1 AR 096942A1
Authority
AR
Argentina
Prior art keywords
methods
nutritional composition
health
providing
acid
Prior art date
Application number
ARP140102630A
Other languages
English (en)
Inventor
Kuang Chenzhong
Xiao Yan
K Poels Eduard
Jouni Zeina
Hondmann Dirk
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of AR096942A1 publication Critical patent/AR096942A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Métodos para promocionar la salud neuronal y/o desarrollo de un sujeto mediante la provisión de composiciones nutricionales que comprenden ácido docosahexaenoico y ácido a lipoico. La composición nutricional puede además incluir lactoferrina, un prebiótico, un probiótico, y mezclas de los mismos. Adicionalmente métodos para acelerar el desarrollo de la actividad neuronal y/o el fortalecimiento de las señales de sinapsis electroquímicas proveyendo la(s) composición(es) nutricional(es) descritas aquí a un sujeto objetivo. Reivindicación 1: Un método para acelerar la actividad neuronal, caracterizado porque comprende proveer una composición nutricional que comprende una fuente carbohidrato, una fuente de grasa, una fuente proteica, ácido docosahexaenoico, y ácido a lipoico. Reivindicación 5: El método de la reivindicación 1, caracterizado porque la composición nutricional además comprende ácido siálico.
ARP140102630A 2013-07-16 2014-07-16 Métodos para promocionar el desarrollo neuronal y/o la salud AR096942A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/942,827 US9226914B2 (en) 2013-07-16 2013-07-16 Methods for promoting neuronal development and/or health

Publications (1)

Publication Number Publication Date
AR096942A1 true AR096942A1 (es) 2016-02-10

Family

ID=51210794

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140102630A AR096942A1 (es) 2013-07-16 2014-07-16 Métodos para promocionar el desarrollo neuronal y/o la salud

Country Status (12)

Country Link
US (1) US9226914B2 (es)
EP (1) EP3102196A1 (es)
CN (1) CN105358144B (es)
AR (1) AR096942A1 (es)
AU (1) AU2014290767A1 (es)
BR (1) BR112015031416A2 (es)
CA (1) CA2918460A1 (es)
MX (1) MX2016000423A (es)
PH (1) PH12016500025A1 (es)
SG (1) SG11201510330YA (es)
TW (1) TW201542101A (es)
WO (1) WO2015009407A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150290261A1 (en) * 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
US10525016B2 (en) * 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
EP3612570A4 (en) 2017-04-17 2021-01-13 The University of Chicago POLYMERIC MATERIALS FOR THE ADMINISTRATION OF SHORT-CHAIN FATTY ACIDS TO THE INTESTINE FOR HUMAN HEALTH AND DISEASE TREATMENT APPLICATIONS
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN112999198A (zh) * 2021-03-10 2021-06-22 中农宠物营养研究院(江苏)有限公司 基于壳聚糖-Fe包衣的能耐胃酸并肠道靶向释放的合生素微胶囊及其制备方法
CN117045760B (zh) * 2023-07-20 2025-03-28 深圳市金枫生物医药科技有限公司 一种神经修复组合物及其制备方法和应用
CN118614611B (zh) * 2024-07-08 2025-02-14 陕西海斯夫生物工程有限公司 一种能促进大脑发育的营养组合物及其用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DK165090D0 (da) 1990-07-09 1990-07-09 Kem En Tec As Konglomererede partikler
EP1961312A3 (en) 1991-01-24 2010-03-31 Martek Biosciences Corporation Microbial oil mixture and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
DE69524386D1 (de) 1994-02-16 2002-01-17 Pharming Intellectual Pty Bv Isolierung von lactoferrin aus milch
SE9503926D0 (sv) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Adsorptionsförfarande och separationsmedium
GB9715444D0 (en) 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
US6620326B1 (en) 1998-06-18 2003-09-16 Upfront Chromatography A/S Expanded bed adsorption system
US6977046B2 (en) 2000-05-12 2005-12-20 Upfront Chromatography A/S Bed adsorption system
US6332533B1 (en) 2000-08-29 2001-12-25 H.H.H. Incorprorated Media holder mouse pad
AU2002316806B2 (en) 2001-06-01 2007-10-25 Upfront Chromatography A/S Fractionation of protein containing mixtures
AU2003218623B2 (en) 2002-03-07 2008-01-17 Upfront Chromatography A/S A process of isolating lactoferrin
US20050107338A1 (en) 2003-11-17 2005-05-19 Seidman Michael D. Nutritional supplement enhancing mitochondrial function
EP2705849B1 (en) * 2004-07-19 2018-04-04 N.V. Nutricia A preparation for use of aspartate for regulating glucose levels in blood
US8883814B2 (en) 2006-06-05 2014-11-11 Keyview Labs, Inc. Compositions and methods for enhancing brain function
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
EP2251030A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and development in infants
EP2258218A1 (en) 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
PH12012500737A1 (en) 2009-10-29 2012-11-26 Nestec Sa Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof
PH12012501050A1 (en) * 2009-12-08 2013-02-04 Nestec Sa Infant formula with probiotics and milk fat globule membrane components
WO2011121151A1 (es) * 2010-03-31 2011-10-06 Vegenat, S.A. Suplemento alimenticio funcional especialmente destinado para la nutrición, prevención y mejora en casos de alteraciones neurológicas, neurodegenerativas o trastornos cognitivos
US8968722B2 (en) * 2010-12-29 2015-03-03 Mead Johnson Nutrition Company Milk-based nutritional compositions containing lactoferrin and uses thereof
CN102318827B (zh) 2011-07-15 2013-02-27 浙江康恩贝健康产品有限公司 一种促进神经系统发育的营养素组合物及保健品
EP2609814A1 (en) 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of cognitive function
US20140179775A1 (en) 2012-02-29 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
US20140199265A1 (en) 2013-01-11 2014-07-17 Mead Johnson Nutrition Company Nutritional compositions containing a neurologic component and uses thereof

Also Published As

Publication number Publication date
AU2014290767A1 (en) 2015-12-24
HK1221658A1 (zh) 2017-06-09
WO2015009407A1 (en) 2015-01-22
TW201542101A (zh) 2015-11-16
EP3102196A1 (en) 2016-12-14
BR112015031416A2 (pt) 2017-07-25
MX2016000423A (es) 2016-04-20
CN105358144A (zh) 2016-02-24
SG11201510330YA (en) 2016-01-28
US20150023923A1 (en) 2015-01-22
PH12016500025A1 (en) 2016-03-28
US9226914B2 (en) 2016-01-05
CA2918460A1 (en) 2015-01-22
CN105358144B (zh) 2018-05-11

Similar Documents

Publication Publication Date Title
AR096942A1 (es) Métodos para promocionar el desarrollo neuronal y/o la salud
MX383753B (es) Modulación de la expresión similar a la angiopoyetina tipo 3.
MX382230B (es) Composiciones y metodos para modular la expresion de similar a la angiopoyetina tipo 3.
MX2021014709A (es) Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes.
AR097110A1 (es) Composiciones nutricionales que contienen una combinación sinérgica y usos de las mismas
MX2015007933A (es) Oligosacaridos de leche humana para mejorar sintomas de estres.
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
MX393928B (es) Composiciones alergénicas mixtas y métodos de uso de las mismas.
CL2017002184A1 (es) Composición que comprende sialillactosa para usar en la mejora de las aptitudes de aprendizaje y la función de memoria.
BR112015006402A2 (pt) conjunto de pelo menos uma proteína vegetal e pelo menos uma proteína láctea
MX2017016345A (es) Proteinas de fusion para inhibir la angiogenesis.
BR112015015870A2 (pt) composição farmacêutica
AR104835A1 (es) Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas
AR106644A1 (es) Composiciones nutricionales sinergísticas y usos de las mismas
BR112014011251B8 (pt) alimentos para animais de estimação
AR098703A1 (es) Composición alimenticia para baño de oblea para helados y método para su elaboración
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
MX373650B (es) Triheptanoina para el tratamiento de la deficiencia del transportador de glucosa 1.
PE20150359A1 (es) Manejo dietetico de la enfermedad celiaca y alergia alimentaria
MX2016000187A (es) Composiciones y metodos para mejorar el rendimiento del ejercicio.
MX2015002013A (es) Metodos y composiciones utiles para mejorar la salud de huesos y articulaciones.
AR110344A1 (es) Métodos y regímenes de alimentación que comprenden la administración de composiciones nutricionales que contienen butirato dietario
BR112018004310A2 (pt) derivados de espinosina e método de preparação
PE20150908A1 (es) Fortificador de la formula
AR096941A1 (es) Métodos para promocionar el desarrollo y/o la salud neuronal y composición nutricional

Legal Events

Date Code Title Description
FB Suspension of granting procedure